BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15707736)

  • 1. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology.
    Dreu R; Sirca J; Pintye-Hodi K; Burjan T; Planinsek O; Srcic S
    Int J Pharm; 2005 Mar; 291(1-2):99-111. PubMed ID: 15707736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
    Balaxi M; Nikolakakis I; Kachrimanis K; Malamataris S
    J Pharm Sci; 2009 Feb; 98(2):676-89. PubMed ID: 18548618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
    Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
    Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrusion-spheronisation of microcrystalline cellulose pastes using a non-aqueous liquid binder.
    Mascia S; Seiler C; Fitzpatrick S; Wilson DI
    Int J Pharm; 2010 Apr; 389(1-2):1-9. PubMed ID: 20123008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of drying technique on extrusion-spheronisation granules and tablet properties.
    Song B; Rough SL; Wilson DI
    Int J Pharm; 2007 Mar; 332(1-2):38-44. PubMed ID: 17071030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of starch-based pellets via extrusion/spheronisation.
    Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of mass transfer during spheronisation.
    Koester M; Thommes M
    AAPS PharmSciTech; 2012 Jun; 13(2):493-7. PubMed ID: 22415640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
    Elsergany RN; Lenhart V; Kleinebudde P
    Eur J Pharm Biopharm; 2020 Aug; 153():285-296. PubMed ID: 32599270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drying rate on porosity and tabletting behaviour of cellulose pellets.
    Berggren J; Alderborn G
    Int J Pharm; 2001 Oct; 227(1-2):81-96. PubMed ID: 11564543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drying behaviour of two sets of microcrystalline cellulose pellets.
    Berggren J; Alderborn G
    Int J Pharm; 2001 May; 219(1-2):113-26. PubMed ID: 11337172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factorial designed experiment to study the effects of excipients on the mechanical properties of pellets.
    Bashaiwoldu AB; Podczeck F; Newton JM
    J Pharm Pharmacol; 2006 Oct; 58(10):1305-9. PubMed ID: 17034652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables.
    Santos H; Veiga F; Pina M; Podczeck F; Sousa J
    Int J Pharm; 2002 Oct; 246(1-2):153-69. PubMed ID: 12270618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets.
    Bashaiwoldu AB; Podczeck F; Newton JM
    Eur J Pharm Sci; 2004 Feb; 21(2-3):119-29. PubMed ID: 14757483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of structure and properties of granules containing microcrystalline cellulose and polyvinylpyrrolidone during high-shear wet granulation.
    Osei-Yeboah F; Feng Y; Sun CC
    J Pharm Sci; 2014 Jan; 103(1):207-15. PubMed ID: 24218097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption.
    Franceschinis E; Voinovich D; Grassi M; Perissutti B; Filipovic-Grcic J; Martinac A; Meriani-Merlo F
    Int J Pharm; 2005 Mar; 291(1-2):87-97. PubMed ID: 15707735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.